The impact of additional life-table variables on excess mortality estimates

Statistics in Medicine

Volumn 31, Issue 30, 2012, Pages 4219-4230

  Grafféo, Nathalie ^a   Jooste, Valérie ^b   Giorgi, Roch ^a,c  

^a AIX MARSEILLE UNIV   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

Bias (epidemiology); Colon cancer; Excess mortality; Life tables; Population based study

Indexed keywords

ARTICLE; COLORECTAL CANCER; FOLLOW UP; HUMAN; LIFE TABLE; MORTALITY; POPULATION RESEARCH; PROGNOSIS; SIMULATION; STATISTICAL MODEL;

ADULT; AGED; BIAS (EPIDEMIOLOGY); COLONIC NEOPLASMS; COMPUTER SIMULATION; FEMALE; FRANCE; HUMANS; LIFE TABLES; LINEAR MODELS; MALE; MIDDLE AGED; MORTALITY; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SURVIVAL ANALYSIS;

EID: 84870867945     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.5493     Document Type: Article

References (40)

1. Grosclaude P, Colonna M, Hedelin G, Tretarre B, Arveux P, Mace Lesec'h J, Raverdy N, Sauvage-Machelard M. Survival of women with breast cancer in France: variation with age, stage and treatment. Breast Cancer Research and Treatment 2001; 70(2):137-143. DOI: 10.1023/A:1012974728007.
2. Bossard N, Velten M, Remontet L, Belot A, Maarouf N, Bouvier AM, Guizard AV, Tretarre B, Launoy G, Colonna M, Danzon A, Molinie F, Troussard X, Bourdon-Raverdy N, Carli PM, Jaffre A, Bessaguet C, Sauleau E, Schvartz C, Arveux P, Maynadie M, Grosclaude P, Esteve J, Faivre J. Survival of cancer patients in France: a population-based study from the association of the French cancer registries (FRANCIM). European Journal of Cancer 2007; 43:149-160. DOI: 10.1016/j.ejca.2006.07.021.
3. Coleman MP, Quaresma M, Berrino F, Lutz J, De Angelis R, Capocaccia R, Baili P et al.Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncology 2008; 9(8):730-756. DOI: 10.1016/S1470-2045(08)70179-7.
4. Ederer F, Heise H. The effect of eliminating deaths from cancer in general population survival rates, August 1959. methodological note 11, End Result Evaluation Section, National Cancer Institute.
5. Engeland A, Haldorsen T, Dickman PW, Hakulinen T, Moller TR, Storm HH, Tulunius H. Relative survival of Cancer Patients. A comparison between Denmark and the Other Nordic Countries. Acta Oncologica 1998; 37:49-59. DOI: 10.1080/028418698423177.
6. Sant M, Capocaccia R, Verdecchia A, Esteve J, Gatta G, Micheli A, Coleman MP, Berrino F. Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working Group. International Journal of Cancer 1998; 77:679-683. DOI: 10.1002/(SICI)1097-0215(19980831)77:5<679::AID-IJC3>3.0.CO;2-S.
7. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. National Cancer Institute Monograph 1961; 6:101-121.
8. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38:933-942.
9. Esteve J, Benhamou E, Croasdale M, Raymond L. Relative survival and the estimation of net survival: elements for further discussion. Statistics in Medicine 1990; 9:529-538. DOI: 10.1002/sim.4780090506.
10. Hakulinen T, Tenkanen L. Regression analysis of relative survival rates. Applied Statistics 1987; 36:309-317. DOI: 10.2307/2347789.
11. Monnet E, Boutron MC, Arveux P, Milan C, Faivre J. Different multiple regression models for estimating survival: use in a population-based series of colorectal cancers. Journal of Clinical Epidemiology 1992; 45:267-273. DOI: 10.1016/0895-4356(92)90086-3.
12. Rèseau F. Survie des Patients Atteints de Cancer en France. Étude des Registres de Cancers du Réseau Francim. Springer-Verlag: France Paris, 2007.
13. Dignam JJ, Colangelo L, Tian W, Jones J, Smith R, Wickerham DL, Wolmark N. Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. Journal of National Cancer Institute 1999; 91(22):1933-1940. DOI: 10.1093/jnci/91.22.1933.
14. Gregorio DI, Cummings KM, Michalek A. Delay, stage of disease, and survival among white and black women with breast cancer. American Journal of Public Health 1983; 73:590-593.
15. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds).SEER Cancer Statistics Review, 1975-2008, 2011. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site (accessed April, 2012).
16. Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) program population-based study. Archives of Internal Medicine 2002; 162:1985-1993.
17. Schrijvers CT, Mackenbach JP. Cancer patient survival by socioeconomic status in seven countries: a review for six common cancer sites. Journal of Epidemiology and Community Health 1994; 48:441-446.
18. Chirikos TN, Horner RD. Economic status and survivorship in digestive system cancers. Cancer 1985; 56:210-217. DOI: 10.1002/1097-0142(19850701)56:1<210::AID-CNCR2820560136>3.0.CO;2-E.
19. Dickman PW, Auvinen A, Voutilainen ET, Hakulinen T. Measuring social class differences in cancer patient survival: is it necessary to control for social class differences in general population mortality? A Finnish population-based study. Journal of Epidemiology and Community Health 1998; 52:727-734. DOI: 10.1136/jech.52.11.727.
20. Coleman MP, Babb P, Sloggett A, Quinn M, De Stavola B. Socioeconomic inequalities in cancer survival in England and Wales. Cancer 2001; 91(Suppl 1):208-216. DOI: 10.1002/1097-0142(20010101)91:1+<208::AID-CNCR6>3.0.CO;2-E.
21. Rachet B, Ellis L, Maringe C, Chu T, Nur U, Quaresma M, Shah A, Walters S, Woods L, Forman D, Coleman MP. Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. British Journal of Cancer 2010; 103:446-453. DOI: 10.1038/sj.bjc.6605752.
22. Møller H, Sandlin F, Robinson D, Bray F, Klint Â, Linklater KM, Lambert PC, Påhlman L, Holmberg L, Morris E. Colorectal cancer survival in socioeconomic groups in England: variation is mainly in the short term after diagnosis. European Journal of Cancer 2012; 48(1):46-53. DOI: 10.1016/j.ejca.2011.05.018.
23. Baili P, Micheli A, De Angeli R, Weir HK, Francisci S, Santaquilani M, Hakulinen T, Quaresma M, Coleman MP, and the CONCORD Working Group.Life tables for world-wide comparison of relative survival for cancer (CONCORD study). Tumori 2008; 94:658-668.
24. Remontet L, Bossard N, Belot A, Estève J, and the French network of cancer registries FRANCIM.An overall strategy based on regression models to estimate relative survival and model the estimation of the effects of prognostic factors in cancer survival studies. Statistics in Medicine 2007; 26:2214-2228. DOI: 10.1002/sim.2656.
25. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Statistics in Medicine 2004; 23(1):51-64. DOI: 10.1002/sim.1597.
26. Smith PL. Splines: as a useful and convenient statistical tool. The American Statistician 1979; 33(2):57-62.
27. Durrleman S, Simon R. Flexible regression model with cubic splines. Statistics in Medicine 1989; 8:551-561. DOI: 10.1002/sim.4780080504.
28. Abrahamowicz M, MacKenzie T, Esdaile JM. Time-dependent hazard ratio: modeling and hypothesis testing with application in lupus nephritis. Journal of the American Statistical Association 1996; 91:1432-1439.
29. Quantin C, Abrahamowicz M, Moreau T, Bartlett G, MacKenzie T, Tazi MA, Lalonde L, Faivre J. Variation overtime of the estimation of the effects of prognostic factors in a population-based study of colon cancer: comparison of statistical models. American Journal of Epidemiology 1999; 150:1188-1200.
30. Giorgi R, Abrahamowicz M, Quantin C, Bolard P, Esteve J, Gouvernet J, Faivre J. A relative survival regression model using B-spline functions to model non-proportional hazards. Statistics in Medicine 2003; 22:2767-2784. DOI: 10.1002/sim.1484.
31. R Development Core Team.R: A language and environment for statistical computing, R Foundation for Statistical Computing, Vienna, Austria, 2009. Available on line at http://www.r-project.org/ (accessed April 2012).
32. Le Teuff G, Abrahamowicz M, Bolard P, Quantin C. Comparison of Cox's and relative survival models when estimating the estimation of the effects of prognostic factors on disease-specific mortality: a simulation study under proportional excess hazards. Statistics in Medicine 2005; 24:3887-3909. DOI: 10.1002/sim.2656.
33. Mudholkar GS, Srivastava DK, Kollia GD. A generalization of the Weibull distribution with application to the analysis of survival data. Journal of the American Statistical Association 1996; 91:1575-1583. DOI: 10.2307/2291583.
34. Ross SM. Simulation, Fourth Edition. Elsevier Academic Press: Amsterdam, 2006.
35. Micheli A, Baili P, Quinn M, Mugno E, Capocaccia R, Grosclaude P, and the EUROCARE Working Group.Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. Annals of Oncology 2003; 14(Suppl 5):v28-v40. DOI: 10.1093/annonc/mdg752.
36. Sarfati D, Blakelyl T, Pearce N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. International Journal of Epidemiology 2010; 39:598-610. DOI: 10.1093/ije/dyp392.
37. Howlader N, Ries LAG, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. Journal of National Cancer Institute 2010; 102:1584-1598. DOI: 10.1093/jnci/djq366.
38. Ashworth TG. Inadequacy of death certification: proposal for change. Journal of Clinical Pathology 1991; 44:265-268. DOI: 10.1136/jcp.44.4.265.
39. Percy C, Stanek EI, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. American Journal of Public Health 1981; 71:242-250.
40. Cheuvart B, Ryan L. Adjusting for age-related competing mortality in long-term cancer clinical trials. Statistics in Medicine 1991; 10:65-77. DOI: 10.1002/sim.4780100112.